Article Information
History
- May 28, 2019.
Article Versions
- Version 1 (May 27, 2019 - 13:44).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zoila A. Lopez-Bujanda1,2,3,
- Michael C. Haffner1,
- Matthew G. Chaimowitz3,
- Nivedita Chowdhury1,2,3,
- Nicholas J. Venturini3,
- Aleksandar Obradovic3,
- Corey S. Hansen4,
- Joanna Jacków4,
- Karen S. Sfanos1,5,
- Charles J. Bieberich6,7,
- Paula J. Hurley5,
- Mark J. Selby8,
- Alan J. Korman8,9,
- Angela M. Christiano4,10,
- Angelo M. De Marzo1,5 and
- Charles G. Drake3,11,12,*
- 1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 2Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA
- 3Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA
- 4Department of Dermatology, Columbia University, New York, NY, USA
- 5Departments of Urology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 6Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, Maryland
- 7University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland
- 8Bristol-Myers Squibb, Redwood City, CA, USA
- 9Vir Biotechnology, San Francisco, CA
- 10Department of Genetics & Development, Columbia University, New York, NY, USA
- 11Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
- 12Department of Medicine, Division of Hematology/Oncology, Columbia University, New York, NY, USA
- ↵*Correspondence and request for materials should be addressed to C.G.D. (cgd2139{at}cumc.columbia.edu).